Patent · US Expired

Endothelin antagonists

US6124341A · kind A · utility

11Cited by
7References
36Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 29, 1998
Grant dateSep 26, 2000
Priority date
Expiry dateMay 29, 2018

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P9/00
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

A compound of the formula (I): ##STR1## or a pharmaceutically acceptable salt thereof is disclosed, as well as processes for and intermediates in the preparation thereof, and a method of antagonizing endothelin.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.